These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 2790678
21. A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. Gadducci A, Ferdeghini M, Prontera C, Giordano P, Cristofani R, Bianchi R, Fioretti P. Eur J Gynaecol Oncol; 1990; 11(4):283-8. PubMed ID: 2245812 [Abstract] [Full Text] [Related]
22. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix. Lehtovirta P, Viinikka L, Ylikorkala O. Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974 [Abstract] [Full Text] [Related]
23. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix]. Göcze P, Vahrson H. Orv Hetil; 1992 Dec 13; 133(50):3191-4. PubMed ID: 1461640 [Abstract] [Full Text] [Related]
24. [Determination of the SCC antigen in the serum of patients with cervical cancer]. Crombach G, Würz H, Bolte A. Geburtshilfe Frauenheilkd; 1987 Jul 13; 47(7):439-45. PubMed ID: 3623046 [Abstract] [Full Text] [Related]
25. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125. Verlooy H, Devos P, Janssens J, Mortelmans L, Gerits M, Bonte J, De Roo M. Gynecol Obstet Invest; 1991 Jul 13; 32(1):55-8. PubMed ID: 1765320 [Abstract] [Full Text] [Related]
26. Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma. Maiman M, Feuer G, Fruchter RG, Shaw N, Boyce J. Gynecol Oncol; 1989 Sep 13; 34(3):312-6. PubMed ID: 2767521 [Abstract] [Full Text] [Related]
27. SCC antigen measured in malignant and nonmalignant diseases. Molina R, Filella X, Torres MD, Ballesta AM, Mengual P, Cases A, Balaque A. Clin Chem; 1990 Feb 13; 36(2):251-4. PubMed ID: 2302769 [Abstract] [Full Text] [Related]
28. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC. Gynecol Oncol; 2000 Jan 13; 76(1):103-6. PubMed ID: 10620449 [Abstract] [Full Text] [Related]
29. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy. Micke O, Bruns F, Schäfer U, Prott FJ, Willich N. Anticancer Res; 2005 Jan 13; 25(3A):1663-6. PubMed ID: 16033078 [Abstract] [Full Text] [Related]
30. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy. Ogino I, Nakayama H, Okamoto N, Kitamura T, Inoue T. Int J Gynecol Cancer; 2006 Jan 13; 16(3):1094-100. PubMed ID: 16803491 [Abstract] [Full Text] [Related]
31. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix. Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ. Int J Gynecol Cancer; 2017 Jun 13; 27(5):994-1000. PubMed ID: 28498239 [Abstract] [Full Text] [Related]
34. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers]. Geyer H, Schwörer D, Pfleiderer A. Geburtshilfe Frauenheilkd; 1989 Mar 13; 49(3):266-71. PubMed ID: 2721888 [Abstract] [Full Text] [Related]
35. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. van der Sijde R, de Bruijn HW, Krans M, Bouma J, Aalders JG. Gynecol Oncol; 1989 Nov 13; 35(2):227-32. PubMed ID: 2807015 [Abstract] [Full Text] [Related]
36. [Diagnostic value of SCC-TA4 determination in 4 localizations of epidermoid cancers. An experience of the FNCLCC subgroup of radio-analysis]. Daver A, Dalifard I, Pons-Anicet D, Krebs BP, Gosselin P, Cazin JL, Ricolleau G, Gaillard G, Gachon F, Goussard J. Bull Cancer; 1990 Nov 13; 77(8):781-92. PubMed ID: 2207367 [Abstract] [Full Text] [Related]
37. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Senekjian EK, Young JM, Weiser PA, Spencer CE, Magic SE, Herbst AL. Am J Obstet Gynecol; 1987 Aug 13; 157(2):433-9. PubMed ID: 3475982 [Abstract] [Full Text] [Related]
38. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. Scambia G, Benedetti Panici P, Foti E, Amoroso M, Salerno G, Ferrandina G, Battaglia F, Greggi S, De Gaetano A, Puglia G. J Clin Oncol; 1994 Nov 13; 12(11):2309-16. PubMed ID: 7964945 [Abstract] [Full Text] [Related]
39. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study. Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S. PLoS One; 2015 Nov 13; 10(4):e0122361. PubMed ID: 25860888 [Abstract] [Full Text] [Related]